A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
Merluzzi
V J
VJ
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.
Rosenthal
A S
AS
D000998:Antiviral Agents / Q000494:pharmacology*; D001381:Azepines / Q000494:pharmacology*; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000494:pharmacology*; D012194:RNA-Directed DNA Polymerase / Q000187:drug effects; D018894:Reverse Transcriptase Inhibitors
D000998:Antiviral Agents; D001381:Azepines; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase